Rosetta Omics

1 known investors

Rosetta Omics develops an AI-powered platform that integrates spatial omics, proteomics, and gene expression analysis to enable precision oncology. The platform delivers personalized treatment guidance for cancer patients by analyzing tissue biopsies to predict treatment response and identify clinically relevant biomarkers.